Teva's Q1 Results: Is the Stock About to Crash?
The company met analyst expectations for revenue and profitability, yet that's not necessarily a good thing.
Stay updated with breaking news from Kare Schultz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The company met analyst expectations for revenue and profitability, yet that's not necessarily a good thing.
The company met analyst expectations for revenue and profitability, yet that's not necessarily a good thing.
The Israeli pharmaceutical company has cut 2022 revenue guidance.
By Dietrich Knauth (Reuters) - Rhode Island's attorney general on Monday announced settlements he valued at $107 million against the drugmakers Teva P...
Rhode Island's attorney general on Monday announced settlements he valued at $107 million against the drugmakers Teva Pharmaceutical Industries and AbbVie's Allergan unit to resolve claims over... | March 21, 2022